Table 2.
Serum GDF15 levels before and after thionamide treatment in hyperthyroid subjects.
| Before | After | P-value | |
|---|---|---|---|
| N | 43 | 43 | |
| Weight (kg) | 52.23 ± 6.26 | 57.00 ± 7.33 | <0.01 |
| ALT (U/L) | 37.81 ± 15.92 | 20.98 ± 9.32 | <0.001 |
| AST (U/L) | 30.98 ± 12.28 | 20.63 ± 6.81 | <0.001 |
| TBIL (mmol/L) | 14.66 ± 7.47 | 12.08 ± 4.32 | 0.053 |
| DBIL (mmol/L) | 4.88 ± 3.25 | 3.56 ± 1.61 | 0.019 |
| FINS (mm/L) | 10.69 ± 13.1 | 8.85 ± 6.81 | 0.416 |
| FPG (mM) | 5.14 ± 0.76 | 5.01 ± 0.44 | 0.335 |
| TG (mM) | 0.99 ± 0.68 | 1.11 ± 0.62 | 0.392 |
| TC (mM) | 3.66 ± 0.87 | 5.50 ± 1.01 | <0.001 |
| HDL-c (mM) | 1.37 ± 0.39 | 1.66 ± 0.32 | <0.001 |
| Free T3 (pM) | 26.62 ± 19.40 | 4.53 ± 0.83 | <0.001 |
| Free T4 (pM) | 66.24 ± 32.78 | 13.05 ± 2.63 | <0.001 |
| TSH (mIU/L) | 0.011 ± 0.016 | 0.86 ± 1.28 | <0.001 |
| GDF15 (pmol/L) | 293.27 ± 119.49 | 118.10 ± 71.83 | <0.001 |
Data are presented as means ± standard deviation (SD).